Condition
Diabetic Macular Edema (DME) clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Diabetic Macular Edema (DME) clinical trials that are recruiting, at sites in 9 countries (most in United States (5), China (3), Japan (1)). 1 was first registered in the last 30 days. By phase: Phase 3 (3), Phase 4 (2), Phase 2 (2), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 1New in 30 days
- 9Countries
Newest Diabetic Macular Edema (DME) clinical trials
All recruiting trials (11)
-
Oral N-Acetylcysteine for Diabetic Macular Edema
This study tests whether taking N-acetylcysteine by mouth can help people with center-involving diabetic macular edema who don’t yet need anti-VEGF therapy.
-
4D-150 gene therapy injected into the eye for adults with diabetic macular edema
This study tests whether a one-time intravitreal injection of 4D-150 can help adults with diabetic macular edema compare to aflibercept.
-
Corticosteroid for Diabetic Macular Edema (DME) in Adults with Diabetic Retinopathy
This trial tests whether intravitreal corticosteroid injections can influence inflammatory biomarkers and improve DME in adults with type 2 diabetes.
-
Oral BGE-102 for center-involved diabetic macular edema (Phase 2)
This trial tests whether taking BGE-102 by mouth, alone or with an anti-VEGF drug, can help preserve or improve vision in adults with center-involved diabetic macular edema.
-
Tabirafusp Tedromer vs Aflibercept for Diabetic Macular Edema (DME)
This study tests whether Tabirafusp Tedromer can work as well as or better than Aflibercept to help people with Diabetic Macular Edema.
-
Early imaging changes with faricimab versus biosimilar ranibizumab for diabetic retinal disease
This trial will see if faricimab or a biosimilar ranibizumab causes different early OCT and OCTA imaging changes in adults with diabetic retinopathy or diabetic macular edema who need anti-VEGF injections.
-
Comparing BAT5906 and Lucentis for diabetic macular edema
This test will see if BAT5906 works as well as Lucentis to improve vision in adults with diabetic macular edema.
-
LX111 gene therapy for adults with diabetic macular edema.
This treatment will try a single eye injection of LX111 gene therapy in adults with diabetic macular edema to see if it is safe and reduces retinal swelling and improves vision.
-
Effects of Faricimab on kidney function in diabetic patients
This study is testing if a new eye injection called Faricimab can help improve kidney function in people with diabetes compared to a standard treatment.
-
Investigating metabolic and lipid profiles in diabetic eye disease
This study is trying to see how blood and urine samples from people with diabetes relate to eye damage caused by diabetic eye disease and if gut bacteria play a role in this.
-
High-dose aflibercept for diabetic macular edema after vitrectomy
We will try a higher dose of aflibercept (8 mg) to see if it better controls diabetic macular edema in people who have had vitrectomy.
Related topics
Quick answers
How many Diabetic Macular Edema (DME) clinical trials are recruiting right now?
11, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (5 trials), China (3 trials), Japan (1 trial), Puerto Rico (1 trial), Egypt (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 4: 2, Phase 2: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.